IFP Advisors’s Alzamend Neuro ALZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4
Closed -$1.19K 3048
2023
Q3
$1.19K Hold
4
﹤0.01% 2960
2023
Q2
$3.06K Hold
4
﹤0.01% 2724
2023
Q1
$62.1K Hold
4
﹤0.01% 1469
2022
Q4
$62K Buy
+4
New +$5.79K ﹤0.01% 2082

Other funds holding ALZN

IFP Advisors's ALZN Position: Q4 2023 in Review

IFP Advisors sold out of Alzamend Neuro (ALZN) in Q4 2023, closing a stake of 4 shares — an estimated $1.19K sold.

IFP Advisors first reported a position in ALZN in Q4 2022 and held it in 4 quarters. The position peaked at $62.1K in Q1 2023. 14 funds tracked by Wall St. Rank hold ALZN as of Q4 2023.

  • IFP Advisors reported no remaining Alzamend Neuro position as of Q4 2023 after selling out during the quarter.
  • IFP Advisors sold 4 Alzamend Neuro shares in Q4 2023, an estimated $1.19K.
  • IFP Advisors first reported a position in Alzamend Neuro in Q4 2022 and held it in 4 quarters.
  • IFP Advisors's Alzamend Neuro position peaked at $62.1K in Q1 2023.
  • 14 funds tracked by Wall St. Rank held Alzamend Neuro as of Q4 2023.

Based on IFP Advisors's 13F filing for Q4 2023, filed 9 Jan 2024.